Close
Nordic 9Nordic 9

Trio Impact Invest (investor - Venture Capital)

Sweden trioimpactinvest.se
See something wrong or missing? Let us know
Offices:Stockholm

Trio Impact Invest is an investment vehicle founded in Sweden by KTH Holding AB, Karolinska Institutet Holding AB and SU Holding AB in order to invest in early stage deeptech startups in the region of Stockholm

Average round investment:N/A USD
Average number per year:0.0
Distribution: 2026 (1)
Portfolio companies: Sweden AAX Biotech
Mostly invests in: Sweden Sweden (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Trio Impact Invest

Name Criteria
Sweden Triathlon Group
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
Sweden Ekeblad Bostad
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
United States Signet Healthcare Partners
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
United Kingdom UpRoot Capital
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
Switzerland SNGLR Capital
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Austria Biogena Group Invest Ag
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Spain FC Barcelona
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Belgium Annemie Van de Casteele
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Belgium Griet Nuytinck
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Belgium Virginie Saverys
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Top